Therapeutic Mechanisms Debuting in April 2026 Glaucoma Trials
Earlier trial results. A recent Phase III study (NCX 470) and others confirmed that combined outflow enhancers can beat traditional drops. For...
Deep research and expert guides on maintaining your visual health.
Earlier trial results. A recent Phase III study (NCX 470) and others confirmed that combined outflow enhancers can beat traditional drops. For...
Track peripheral vision changes between eye doctor visits. Start your free trial and get results in under 5 minutes.
Fibrosis prevention is about stopping or reducing the formation of scar tissue after injury, surgery, or chronic inflammation. Scar tissue forms when the body's repair process goes into overdrive and lays down extra connective material, which can stiffen or block normal tissues and interfere with their function. Preventing fibrosis matters because excessive scarring can lead to organ dysfunction, failed surgical repairs, or long-term pain and disability. Strategies to prevent fibrosis include drugs that block the signals that cause scar-forming cells to activate, careful surgical techniques, and materials that encourage healthier healing. Researchers also study targeted molecules, gene-based approaches, and localized drug delivery to limit scarring without shutting down normal repair. Effective prevention can improve outcomes after procedures and reduce the need for repeat surgeries or long-term treatments. There are challenges, such as timing the intervention correctly and avoiding unwanted effects on normal healing and immunity. The goal is to guide the body’s repair process so it restores tissue without leaving harmful, stiff scars.